NCT01341262 THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM) Status COMPLETED Phase PHASE2
NCT01339260 An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting Status COMPLETED Phase PHASE3
NCT01337752 Study in Patients With Untreated Multiple Myeloma and Renal Insufficiency Status COMPLETED Phase PHASE2
NCT01335399 Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma Status COMPLETED Phase PHASE3
NCT01332812 Dexamethasone for the Prevention of Postoperative Cognitive Dysfunction Status COMPLETED Phase PHASE4
NCT01331590 Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia Status COMPLETED Phase EARLY_PHASE1
NCT01329289 SOM230 LAR With Bortezomib and Dexamethasone for Refractory or Relapsed Multiple Myeloma Status WITHDRAWN Phase PHASE2
NCT01328236 Bortezomib in Combination With Liposomal Doxorubicin and Dexamethasone to Treat Plasma Cell Leukemia Status UNKNOWN Phase PHASE2
NCT01324180 Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE1
NCT01319981 Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT01318902 Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain Amyloidosis Status COMPLETED Phase PHASE1
NCT01312818 Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) Status TERMINATED Phase PHASE2
NCT01311687 A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Combination With Low-Dose Dexamethasone Versus High-Dose Dexamethasone in Subjects With Refractory Multiple Myeloma or Relapsed and Refractory Multiple Myeloma and Companion Study Status COMPLETED Phase PHASE3
NCT01311167 Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone Status TERMINATED Phase PHASE3
NCT01303003 Evaluation of Addition of Dexamethasone to Transversus Abdominis Plane (TAP) Peripheral Nerve Block Status COMPLETED Phase NA
NCT01298076 Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema Status COMPLETED Phase PHASE2
NCT01297686 Exercise Versus Corticosteroid Randomized Clinical Trial for Plantar Fasciitis Status COMPLETED Phase PHASE2/PHASE3
NCT01297010 Dexamethasone Compared to Ondansetron and Dexamethasone for Prophylaxis of Postoperative Vomiting in Children Status COMPLETED Phase PHASE3
NCT01296503 Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple Myeloma Status COMPLETED Phase PHASE3